Role of prothrombin complex concentrate in perioperative coagulation therapy

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Tanaka, Kenichi A ^a   Mazzeffi, Michael ^a   Durila, Miroslav ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Coagulation; Factor eight bypassing agent; Fresh frozen plasma; Prothrombin complex concentrate; Recombinant activated factor VII; Thromboelastometry

Indexed keywords

PROTHROMBIN COMPLEX;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; HUMAN; PLASMA TRANSFUSION; PRIORITY JOURNAL; SEPSIS;

EID: 84979197070     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-014-0060-5     Document Type: Article

References (71)

1. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458. 18791365.
2. Inaba K, Lustenberger T, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Talving P, Demetriades D. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010, 211:573-579. 10.1016/j.jamcollsurg.2010.06.392, 20846882.
3. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG, Shulman I, Nelson J, Demetriades D. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010, 210:957-965. 10.1016/j.jamcollsurg.2010.01.031, 20510805.
4. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009, 67:221-227. 10.1097/TA.0b013e3181ad5957, 19667872.
5. Inaba K, Branco BC, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Demetriades D. Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 2010, 145:899-906. 10.1001/archsurg.2010.175, 20855762.
6. Key NS, Negrier C. Coagulation factor concentrates: past, present, and future. Lancet 2007, 370:439-448. 10.1016/S0140-6736(07)61199-4, 17679021.
7. Lin DM, Murphy LS, Tran MH. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev 2013, 27:91-104. 10.1016/j.tmrv.2013.01.002, 23462530.
8. Tanaka KA, Esper S, Bolliger D. Perioperative factor concentrate therapy. Br J Anaesth 2013, 111(Suppl 1):i35-i49. 10.1093/bja/aet380, 24335398.
9. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010, 363:1791-1800. 10.1056/NEJMoa1006221, 21047223.
10. Sarode R, Milling TJ, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation 2013, 128:1234-1243. 23935011.
11. Chhibber V, Greene M, Vauthrin M, Bailey J, Weinstein R. Is group A thawed plasma suitable as the first option for emergency release transfusion?. Transfusion 2014, 54:1751-1755. 10.1111/trf.12537, 24400951.
12. Mehr CR, Gupta R, von Recklinghausen FM, Szczepiorkowski ZM, Dunbar NM. Balancing risk and benefit: maintenance of a thawed group A plasma inventory for trauma patients requiring massive transfusion. J Trauma Acute Care Surg 2013, 74:1425-1431. 10.1097/TA.0b013e31828b813e, 23694868.
13. Thiele T, Kellner S, Hron G, Wasner C, Nauck M, Zimmermann K, Wessel A, Warkentin TE, Greinacher A, Selleng K. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation. Transfusion 2012, 52:529-536. 10.1111/j.1537-2995.2011.03317.x, 21880044.
14. Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 2001, 41:570. 10.1046/j.1537-2995.2001.41040570.x, 11316912.
15. Tholpady A, Monson J, Radovancevic R, Klein K, Bracey A. Analysis of prolonged storage on coagulation factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days?. Transfusion 2013, 53:645-650. 10.1111/j.1537-2995.2012.03786.x, 22803679.
16. Boldt J, Huttner I, Suttner S, Kumle B, Piper SN, Berchthold G. Changes of haemostasis in patients undergoing major abdominal surgery-is there a difference between elderly and younger patients?. Br J Anaesth 2001, 87:435-440. 10.1093/bja/87.3.435, 11517128.
17. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009, 49:2652-2660. 10.1111/j.1537-2995.2009.02335.x, 19682336.
18. Cardigan R, Lawrie AS, Mackie IJ, Williamson LM. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. Transfusion 2005, 45:1342-1348. 10.1111/j.1537-2995.2005.00219.x, 16078924.
19. Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology 2007, 1:179-186. 10.1182/asheducation-2007.1.179.
20. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004, 125:69-73. 10.1111/j.1365-2141.2004.04868.x, 15015971.
21. Kor DJ, Stubbs JR, Gajic O. Perioperative coagulation management-fresh frozen plasma. Best Pract Res Clin Anaesthesiol 2010, 24:51-64. 10.1016/j.bpa.2009.09.007, 20402170.
22. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA, Group TS. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012, 119:1757-1767. 10.1182/blood-2011-08-370932, 22117051.
23. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013, 53:1442-1449. 10.1111/j.1537-2995.2012.03935.x, 23113676.
24. Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009, 49:1171-1177. 10.1111/j.1537-2995.2008.02080.x, 19210325.
25. Imberti D, Barillari G, Biasioli C, Bianchi M, Contino L, Duce R, D'Inca M, Gnani MC, Mari E, Ageno W. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus 2011, 9:148-155. 21251465.
26. Joseph B, Hadjizacharia P, Aziz H, Kulvatunyou N, Tang A, Pandit V, Wynne J, O'Keeffe T, Friese RS, Rhee P. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg 2013, 74:248-253. 10.1097/TA.0b013e3182788a40, 23271101.
27. Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion 2013, 53:920-921. 10.1111/trf.12110, 23565996.
28. Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost 2011, 106:1215-1223. 10.1160/TH11-04-0240, 22071880.
29. Turecek PL, Varadi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004, 10(Suppl 2):3-9. 10.1111/j.1365-2516.2004.00934.x, 15385040.
30. Wojcik C, Schymik ML, Cure EG. Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy. Int J Emerg Med 2009, 2:217-225. 10.1007/s12245-009-0125-8, 20436891.
31. Reply GA, Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica 2008, 93:e24-e26. 10.3324/haematol.12151.
32. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14:R55. 10.1186/cc8948, 20374650.
33. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011, 115:1179-1191. 21970887.
34. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012, 117:531-547. 10.1097/ALN.0b013e318264c644, 22914710.
35. Fassl J, Matt P, Eckstein F, Filipovic M, Gregor M, Zenklusen U, Seeberger MD, Bolliger D. Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth 2013, 27:1181-1188. 10.1053/j.jvca.2013.02.009, 23962459.
36. Tanaka KA, Bolliger D, Vadlamudi R, Nimmo A. Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J Cardiothorac Vasc Anesth 2012, 26:1083-1093. 10.1053/j.jvca.2012.06.015, 22863406.
37. Girdauskas E, Kempfert J, Kuntze T, Borger MA, Enders J, Fassl J, Falk V, Mohr FW. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010, 140:1117-1124. e2, 10.1016/j.jtcvs.2010.04.043, 20951260.
38. Majeed A, Eelde A, Agren A, Schulman S, Holmstrom M. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res 2012, 129:146-151. 10.1016/j.thromres.2011.07.024, 21807399.
39. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013, 27:213-220. 10.1016/j.tmrv.2013.08.004, 24075802.
40. Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T. A specific antidote for dabigatran: functional and structural characterization. Blood 2013, 121:3554-3562. 10.1182/blood-2012-11-468207, 23476049.
41. Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P, Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med 2013, 19:446-451. 10.1038/nm.3102, 23455714.
42. Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Engl J Med 2011, 365:2039-2040. 10.1056/NEJMc1111095, 22111735.
43. Harper P, Young L, Merriman E. Bleeding risk with dabigatran in the frail elderly. N Engl J Med 2012, 366:864-866. 10.1056/NEJMc1112874, 22375994.
44. Garber ST, Sivakumar W, Schmidt RH. Neurosurgical complications of direct thrombin inhibitors-catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. J Neurosurg 2012, 116:1093-1096. 10.3171/2012.2.JNS112132, 22394293.
45. Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 2012, 119:2172-2174. 10.1182/blood-2011-11-393587, 22383791.
46. Tanaka KA, Bolliger D. On the reversal of new oral anti-coagulants: can we simply extrapolate data from the animal models to humans?. Br J Anaesth 2013, 110:329-332. 10.1093/bja/aes502, 23404966.
47. Dickneite G, Hoffman M. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?. Thromb Haemost 2014, 111:189-198. 10.1160/TH13-05-0431, 24136202.
48. Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost 2012, 108:217-224. 10.1160/TH12-03-0179, 22627883.
49. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011, 124:1573-1579. 10.1161/CIRCULATIONAHA.111.029017, 21900088.
50. Zhou W, Schwarting S, Illanes S, Liesz A, Middelhoff M, Zorn M, Bendszus M, Heiland S, van Ryn J, Veltkamp R. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran. Stroke 2011, 42:3594-3599. 10.1161/STROKEAHA.111.624650, 21998060.
51. van Ryn J, Schurer J, Kink-Eiband M, Clemens A. Successful reversal of dabigatran-induced bleeding by 3-factor coagulation concentrates in a rat tail bleeding model: lack of correlation with ex vivo markers of anticoagulation. Circulation 2012, 126.
52. Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology 2012, 116:94-102. 10.1097/ALN.0b013e318238c036, 22042412.
53. Perzborn E, Gruber A, Tinel H, Marzec UM, Buetehorn U, Buchmueller A, Heitmeier S, Laux V. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates. Thromb Haemost 2013, 110:162-172. 10.1160/TH12-12-0907, 23636219.
54. Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke 2013, 44:771-778. 10.1161/STROKEAHA.112.675231, 23339956.
55. Siegal DM, Garcia DA, Crowther MA. How I treat target-specific oral anticoagulant-associated bleeding. Blood 2014, 123:1152-1158. 10.1182/blood-2013-09-529784, 24385535.
56. Durila M, Malosek M. Rotational thromboelastometry along with thromboelastography plays a critical role in the management of traumatic bleeding. Am J Emerg Med 2014, 32:288. e1-3, 10.1016/j.ajem.2013.09.038, 24286666.
57. Yasunaga H. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan. Lancet 2007, 370:2063-2067. 10.1016/S0140-6736(07)61867-4, 18083405.
58. Yamamoto K, Usui A, Takamatsu J. Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair. J Cardiothorac Surg 2014, 9:90. 10.1186/1749-8090-9-90, 24884627.
59. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010, 113:1205-1219. 10.1097/ALN.0b013e3181f22b5a, 20881594.
60. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011, 112:1289-1295. 10.1213/ANE.0b013e318210385c, 21346161.
61. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011, 118:1943-1951. 10.1182/blood-2011-03-343046, 21670472.
62. Mitterlechner T, Innerhofer P, Streif W, Lodl M, Danninger T, Klima G, Hansson K, Fries D. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011, 9:729-737. 10.1111/j.1538-7836.2011.04211.x, 21255250.
63. Hiippala S. Replacement of massive blood loss. Vox Sang 1998, 74(Suppl 2):399-407. 10.1111/j.1423-0410.1998.tb05449.x, 9704474.
64. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010, 104:318-325. doi: 10.1093/bja/aeq001, 10.1093/bja/aeq001, 20133450.
65. Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg 2008, 106:713-718. 10.1213/ane.0b013e3181608f7c, 18292407.
66. Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009, 108:1433-1446. 10.1213/ane.0b013e31819bcc9c, 19372317.
67. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012, 26:1-13. 10.1016/j.tmrv.2011.07.005, 21872428.
68. Tanaka KA, Bader SO, Sturgil EL. Diagnosis of perioperative coagulopathy-plasma versus whole blood testing. J Cardiothorac Vasc Anesth 2013, 27:S9-S15. 10.1053/j.jvca.2013.05.012, 23910538.
69. Hanke AA, Joch C, Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth 2013, 110:764-772. 10.1093/bja/aes501, 23335567.
70. Koster A, Meyer-Jark T, Schirmer U, Sandica E. Fulminant intraoperative right heart and pulmonary artery thrombosis following prothrombin complex concentrate infusion after complex open heart surgery with cardiopulmonary bypass. A&A Case Rep 2014, 2:89-91. 10.1097/ACC.0b013e3182a070e9.
71. Sniecinski RM, Chen EP, Tanaka KA. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis 2008, 19:178-179. 10.1097/MBC.0b013e3282f40d4a, 18277140.